Grifols (GRFS) Change in Account Payables (2010 - 2020)

Grifols (GRFS) posted Change in Account Payables of -$25.7 million for Q1 2020, up 67.14% quarter-over-quarter from -$78.2 million in Q4 2019, and up 53.91% year-on-year from -$16.7 million in Q2 2019.

Grifols (GRFS) Change in Account Payables (2010 - 2020) Analysis & Trends

Grifols (GRFS) has reported Change in Account Payables for 10 consecutive years, with -$25.7 million the latest figure, recorded in Q1 2020.

  • Change in Account Payables for Q1 2020 came in at -$25.7 million, up 53.91% year-over-year; the trailing twelve-month figure through Mar 2020 was -$155.5 million (down 134.7% YoY), and the FY2025 annual result was $109.4 million, up 253.09% from the prior year.
  • Change in Account Payables was -$25.7 million for Q1 2020 at Grifols, up from -$78.2 million in the prior quarter.
  • Over five years, Change in Account Payables peaked at $81.5 million in Q4 2016 and troughed at -$78.2 million in Q4 2019.
  • Average Change in Account Payables over 5 years is -$5.2 million, with a median of $4.2 million recorded in 2018.
  • Year-over-year, Change in Account Payables soared 128.83% in 2016 and slumped 1957.3% in 2019.
  • Over 5 years, Change in Account Payables stood at $81.5 million in 2016, then sank by 40.67% to $48.3 million in 2017, then slumped by 91.29% to $4.2 million in 2018, then plunged by 1957.3% to -$78.2 million in 2019, then jumped by 67.14% to -$25.7 million in 2020.
  • Per Business Quant data, the three most recent Change in Account Payables figures were -$25.7 million in Q1 2020, -$78.2 million in Q4 2019, and -$55.8 million in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 571.00 Mn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -67.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Grifols - - - -

Historic Data

Download Data
DateValue
Mar 31, 2020 -25.70 Mn
Mar 31, 2020 -25.70 Mn
Dec 31, 2019 -78.22 Mn
Dec 31, 2019 -78.22 Mn
Mar 31, 2019 -55.77 Mn
Mar 31, 2019 -55.77 Mn
Dec 31, 2018 4.21 Mn
Dec 31, 2018 4.21 Mn
Jun 30, 2018 -22.71 Mn
Jun 30, 2018 -22.71 Mn
Mar 31, 2018 8.02 Mn
Mar 31, 2018 8.02 Mn
Dec 31, 2017 48.35 Mn
Dec 31, 2017 48.35 Mn
Jun 30, 2017 34.54 Mn
Jun 30, 2017 34.54 Mn
Mar 31, 2017 19.09 Mn
Mar 31, 2017 19.09 Mn
Dec 31, 2016 81.49 Mn
Dec 31, 2016 81.49 Mn